Mathematical modelling of the interaction between cancer cells and an oncolytic virus: insights into the effects of treatment protocols

DOI10.1007/S11538-018-0424-4MaRDI QIDQ1670482zbMATH OpenOpenAlexWikidataFDO

Authors Adrianne L. Jenner, Chae-Ok Yun, Peter S. Kim, Adelle C. F. Coster

Publication date 5 September 2018

Published in Bulletin of Mathematical Biology (Search for Journal in Brave)

Full work available at URL https://arxiv.org/abs/1911.12876

zbMATH Keywords

mathematical modellingoncolytic virusoptimisationordinary differential equations

Mathematics Subject Classification ID

Qualitative investigation and simulation of ordinary differential equation models (34C60) Medical applications (general) (92C50)

Abstract: Oncolytic virotherapy is an experimental cancer treatment that uses genetically engineered viruses to target and kill cancer cells. One major limitation of this treatment is that virus particles are rapidly cleared by the immune system, preventing them from arriving at the tumour site. To improve virus survival and infectivity modified virus particles with the polymer polyethylene glycol (PEG) and the monoclonal antibody herceptin. While PEG modification appeared to improve plasma retention and initial infectivity it also increased the virus particle arrival time. We derive a mathematical model that describes the interaction between tumour cells and an oncolytic virus. We tune our model to represent the experimental data by Kim et al. (2011) and obtain optimised parameters. Our model provides a platform from which predictions may be made about the response of cancer growth to other treatment protocols beyond those in the experiments. Through model simulations we find that the treatment protocol affects the outcome dramatically. We quantify the effects of dosage strategy as a function of tumour cell replication and tumour carrying capacity on the outcome of oncolytic virotherapy as a treatment. The relative significance of the modification of the virus and the crucial role it plays in optimising treatment efficacy is explored.

Recommendations

• scientific article; zbMATH DE number 6720796
• Oncolytic virus treatment of human breast cancer cells: modelling therapy efficacy
• The role of viral infectivity in oncolytic virotherapy outcomes: a mathematical study
• A mathematical model for the role of macrophages in the persistence and elimination of oncolytic viruses
• Analysis of a mathematical model for tumor therapy with a fusogenic oncolytic virus

Cites work

• Treatment strategies for combining immunostimulatory oncolytic virus therapeutics with dendritic cell injections

Cited in

(47)

• A mathematical model of combined therapies against cancer using viruses and inhibitors
• Modelling heterogeneity in viral-tumour dynamics: the effects of gene-attenuation on viral characteristics
• Mathematical modelling of a hypoxia-regulated oncolytic virus delivered by tumour-associated macrophages
• Developing a minimally structured mathematical model of cancer treatment with oncolytic viruses and dendritic cell injections
• A mathematical model for oncolytic virus spread using the telegraph equation
• Application of control theory in a delayed-infection and immune-evading oncolytic virotherapy
• Hopf bifurcation analysis of a tumor virotherapy model with two time delays
• Modeling the virus-induced tumor-specific immune response with delay in tumor virotherapy
• A combination therapy of oncolytic viruses and chimeric antigen receptor T cells: a mathematical model proof-of-concept
• A mathematical model for tumor growth and treatment using virotherapy
• Bistability in a model of tumor-immune system interactions with an oncolytic viral therapy
• Slow-fast model and therapy optimization for oncolytic treatment of tumors
• Multiscale moving boundary modelling of cancer interactions with a fusogenic oncolytic virus: the impact of syncytia dynamics
• Population dynamics with threshold effects give rise to a diverse family of Allee effects
• A cellular automata model of oncolytic virotherapy in pancreatic cancer
• Model-driven approaches for in vitro combination therapy using ONYX-015 replicating oncolytic adenovirus
• A fractional mathematical model of breast cancer competition model
• The role of viral infectivity in oncolytic virotherapy outcomes: a mathematical study
• Oncolytic virotherapy for tumours following a Gompertz growth law
• Multiscale modelling of cancer response to oncolytic viral therapy
• Enhancing oncolytic virotherapy: observations from a Voronoi cell-based model
• Modeling oncolytic virotherapy: is complete tumor-tropism too much of a good thing?
• On a mathematical model of tumor-immune system interactions with an oncolytic virus therapy
• Oncolytic virus treatment of human breast cancer cells: modelling therapy efficacy
• Spatial cumulant models enable spatially informed treatment strategies and analysis of local interactions in cancer systems
• scientific article; zbMATH DE number 6720796 (Why is no real title available?)
• Computational modeling approaches to studying the dynamics of oncolytic viruses
• A mathematical model for the role of macrophages in the persistence and elimination of oncolytic viruses
• Non-local multiscale approaches for tumour-oncolytic viruses interactions
• Mathematical model of optimal chemotherapy and oncolytic virotherapy
• Stability analysis of a fractional virotherapy model for cancer treatment
• Oscillation thresholds via the novel MBR method with application to oncolytic virotherapy
• A mathematical model of viral oncology as an immuno-oncology instigator
• scientific article; zbMATH DE number 5044737 (Why is no real title available?)
• On the treatment of melanoma: a mathematical model of oncolytic virotherapy
• Agent-based and continuum models for spatial dynamics of infection by oncolytic viruses
• Oscillations in a spatial oncolytic virus model
• On the dynamics and optimal control of a mathematical model of neuroblastoma and its treatment: insights from a mathematical model
• Computational modeling of cancer response to oncolytic virotherapy: improving the effectiveness of viral spread and anti tumor efficacy
• A phenotype-structured mathematical model for the influence of hypoxia on oncolytic virotherapy
• Car T-cell and oncolytic virus dynamics and determinants of combination therapy success for glioblastoma
• Modeling the interaction of cytotoxic T-lymphocytes and oncolytic viruses in a tumor microenvironment
• Assessing the impact of immunotherapy on oncolytic virotherapy in the treatment of cancer
• Constrained optimal control problem of oncolytic viruses in cancer treatment
• Quantitative impact of immunomodulation versus oncolysis with cytokine-expressing virus therapeutics
• Effects of CCN1 and macrophage content on glioma virotherapy: a mathematical model
• Analysis of a mathematical model for tumor therapy with a fusogenic oncolytic virus

This page was built for publication: Mathematical modelling of the interaction between cancer cells and an oncolytic virus: insights into the effects of treatment protocols

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q1670482)